腸瘻治療の世界市場レポート 2025年

腸瘻治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.9％で353億5,000万米ドルに成長します。予測期間中の成長は、遠隔医療の導入拡大、可処分所得の増加、クローン病の有病率の増加、高齢化、個別化医療の重視などに起因すると考えられます。この期間に予想される主な動向には、AIを搭載した診断ツール、生物製剤の進歩、医療アプリケーションにおける3Dプリンティングの使用、統合ケアモデル、ウェアラブル健康モニタリングデバイスの採用などがあります。

胃腸（GI）疾患の有病率の上昇は、腸瘻治療市場の成長に大きく寄与すると予想されます。GI障害には、消化管に影響を及ぼし、痛み、腹部膨満感、下痢、便秘などの症状を引き起こす幅広い疾患が含まれ、しばしば医療介入が必要となります。食生活の乱れ、ストレス、精神的健康問題などの要因が、これらの疾患の発生率増加の一因となっています。腸瘻治療は、腸の異常な結合に対処することで、このような疾患の管理に不可欠です。この治療により、これらの結合を閉じ、感染症を予防し、腸の機能を回復させ、栄養不良や敗血症などの合併症を減らすことができます。例えば、2023年9月の米国疾病予防管理センター（CDC）によると、米国では約1,480万人の成人が潰瘍に罹患しており、消化器系の問題で年間3,540万人の医師が受診しています。消化器疾患の有病率が上昇するにつれて、効果的な腸瘻治療に対する需要もそれに応じて高まっています。

ヘルスケア施設の改善も、腸瘻治療市場の成長を促す重要な要因です。病院、クリニック、診断センターなどのヘルスケア施設は、腸瘻などの疾患を持つ患者の治療やサポートに重要な役割を果たしています。これらのヘルスケア施設は、医療インフラへの投資の増加、患者中心のケアの重視、人口増加、人口動態の高齢化などの要因により改善しつつあります。強化されたヘルスケア施設は、腸瘻治療に対する医学的、外科的、栄養学的介入を組み合わせて提供することで、患者の転帰改善に貢献しています。これにより、ケア提供の最適化、合併症の減少、入院期間の短縮、慢性疾患管理の改善が図られます。例えば、2023年5月、米国ヘルスケア協会は、米国の病院数が0.591％増加し、合計6,129病院になったと報告しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界腸瘻治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の腸瘻治療市場：成長率分析
• 世界の腸瘻治療市場の実績：規模と成長, 2019-2024
• 世界の腸瘻治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界腸瘻治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腸瘻治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 手術
• 栄養サポート
• その他の治療タイプ
• 世界の腸瘻治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 直腸
• 非経口
• 世界の腸瘻治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の腸瘻治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• 専門クリニック
• その他のエンドユーザー
• 世界の腸瘻治療市場、医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• 免疫抑制剤
• 抗分泌剤
• 疼痛管理薬
• 世界の腸瘻治療市場、手術の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 瘻孔閉鎖手術
• 腸切除手術
• ストーマ形成手術
• 世界の腸瘻治療市場栄養サポートの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経腸栄養
• 経腸栄養
• 世界の腸瘻治療市場、その他の治療タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高圧酸素療法
• 内視鏡的瘻孔閉鎖術

第7章 地域別・国別分析

• 世界の腸瘻治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の腸瘻治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腸瘻治療市場：競合情勢
• 腸瘻治療市場：企業プロファイル
  • Merck & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medtronic plc
• Eli Lilly and Company
• Moderna Inc.
• Astellas Pharma Inc.
• Boehringer Ingelheim International GmbH
• Cook Group Incorporated
• Integra LifeSciences
• Avante Health Solutions
• Angiplast Pvt. Ltd.
• Angiplast Pvt. Ltd.
• Biolitec AG
• Sklar Surgical Instruments
• Livealth BioPharma
• Surtex Instruments Limited
• Advin Health Care

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腸瘻治療市場2029：新たな機会を提供する国
• 腸瘻治療市場2029：新たな機会を提供するセグメント
• 腸瘻治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Intestinal fistula treatment involves the medical and surgical management of abnormal connections (fistulas) that develop between the intestine and other organs or the skin. Treatment approaches are determined based on the type, location, and severity of the fistula, along with the patient's overall health and the underlying cause of the condition.

The primary treatment options for intestinal fistulas include medications, surgery, nutritional support, and other supportive therapies. Medications are used to manage symptoms and promote healing, administered through various routes such as oral, rectal, and parenteral. These treatments are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and are utilized by various end-users, such as hospitals, ambulatory surgical centers, and specialty clinics.

The intestinal fistula treatment market research report is one of a series of new reports from The Business Research Company that provides intestinal fistula treatment market statistics, including the intestinal fistula treatment industry global market size, regional shares, competitors with the intestinal fistula treatment market share, detailed intestinal fistula treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the intestinal fistula treatment industry. This intestinal fistula treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The intestinal fistula treatment market size has grown strongly in recent years. It will grow from $25.27 billion in 2024 to $27.10 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the increased incidence of gastrointestinal disorders, the rising prevalence of malnutrition, the growing geriatric population, advancements in healthcare infrastructure, and increased healthcare spending.

The intestinal fistula treatment market size is expected to see strong growth in the next few years. It will grow to $35.35 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to the increasing adoption of telemedicine, rising disposable income, the growing prevalence of Crohn's disease, an aging population, and a greater emphasis on personalized medicine. Key trends expected during this period include AI-powered diagnostic tools, advancements in biologics, the use of 3D printing in medical applications, integrated care models, and the adoption of wearable health monitoring devices.

The rising prevalence of gastrointestinal (GI) disorders is expected to significantly contribute to the growth of the intestinal fistula treatment market. GI disorders encompass a wide range of conditions that affect the digestive tract, causing symptoms such as pain, bloating, diarrhea, or constipation, which often require medical intervention. Factors such as poor dietary habits, stress, and mental health issues are contributing to the increasing incidence of these conditions. Intestinal fistula treatment is vital in managing such disorders by addressing abnormal intestinal connections. This treatment helps to close these connections, prevent infections, restore gut function, and reduce complications such as malnutrition and sepsis. For example, according to the Centers for Disease Control and Prevention (CDC) in September 2023, approximately 14.8 million adults in the United States are affected by ulcers, and there are 35.4 million doctor visits annually for digestive issues. As the prevalence of gastrointestinal disorders rises, the demand for effective intestinal fistula treatments grows accordingly.

The improvement in healthcare facilities is another key factor driving the growth of the intestinal fistula treatment market. Healthcare facilities, such as hospitals, clinics, and diagnostic centers, play a crucial role in treating and supporting patients with conditions such as intestinal fistulas. These facilities are improving due to factors such as increased investments in healthcare infrastructure, a focus on patient-centered care, population growth, and aging demographics. Enhanced healthcare facilities contribute to better patient outcomes by offering a combination of medical, surgical, and nutritional interventions for intestinal fistula treatment. This helps optimize care delivery, reduce complications, minimize hospital stays, and improve chronic condition management. For instance, in May 2023, the American Health Care Association reported a 0.591% increase in the number of hospitals in the United States, totaling 6,129 hospitals, which indicates a growing capacity to treat patients, including those requiring intestinal fistula management.

Innovative therapeutic approaches are also playing a pivotal role in advancing the intestinal fistula treatment market. One promising development is mesenchymal stem cell (MSC) therapy, which is being explored for treating refractory perianal fistulas. MSC therapy involves using stem cells to promote tissue healing and regeneration, making it a potential treatment for autoimmune diseases, osteoarthritis, and gastrointestinal disorders. For example, in March 2022, Ossium Health Inc. received an Investigational New Drug (IND) application approval from the U.S. Food and Drug Administration (FDA) for OSSM-001, a mesenchymal stem cell product. This approval enabled the company to proceed with a multi-center Phase 1 clinical trial to assess the safety and feasibility of MSC therapy for fistula healing. The trial is designed to evaluate the safety profile and healing outcomes of this innovative therapy, offering new hope for patients with difficult-to-treat fistulas.

Major players in the intestinal fistula treatment market are Merck & Co. KGaA, Bristol-Myers Squibb, AstraZeneca plc, Pfizer Inc., Medtronic plc, Medtronic plc, Eli Lilly and Company, Moderna Inc., Astellas Pharma Inc., Boehringer Ingelheim International GmbH, Cook Group Incorporated, Integra LifeSciences, Avante Health Solutions, Angiplast Pvt. Ltd., Angiplast Pvt. Ltd., Biolitec AG, Sklar Surgical Instruments, Livealth BioPharma, Surtex Instruments Limited, Advin Health Care.

North America was the largest region in the Intestinal Fistula Treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in intestinal fistula treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the intestinal fistula treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intestinal fistula treatment market consists of revenues of services of medical management, and supportive therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The intestinal fistula treatment market also includes sales of anti-inflammatory drugs, metronidazole, ciprofloxacin and levofloxacin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intestinal Fistula Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intestinal fistula treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intestinal fistula treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intestinal fistula treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Medications; Surgery; Nutritional Support; Other Treatment Type
• 2) By Route Of Administration: Oral; Rectal; Parenteral
• 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 4) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-User
• Subsegments:
• 1) By Medications: Antibiotics; Immunosuppressants; Antisecretory Agents; Pain Management Medications
• 2) By Surgery: Fistula Closure Surgery; Bowel Resection Surgery; Stoma Formation Surgery
• 3) By Nutritional Support: Parenteral Nutrition; Enteral Nutrition
• 4) By Other Treatment Type: Hyperbaric Oxygen Therapy; Endoscopic Fistula Closure
• Companies Mentioned: Merck & Co. KGaA; Bristol-Myers Squibb; AstraZeneca plc; Pfizer Inc.; Medtronic plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intestinal Fistula Treatment Market Characteristics

3. Intestinal Fistula Treatment Market Trends And Strategies

4. Intestinal Fistula Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Intestinal Fistula Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Intestinal Fistula Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Intestinal Fistula Treatment Market Growth Rate Analysis
• 5.4. Global Intestinal Fistula Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Intestinal Fistula Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Intestinal Fistula Treatment Total Addressable Market (TAM)

6. Intestinal Fistula Treatment Market Segmentation

• 6.1. Global Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Surgery
• Nutritional Support
• Other Treatment Type
• 6.2. Global Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Rectal
• Parenteral
• 6.3. Global Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.4. Global Intestinal Fistula Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Other End-User
• 6.5. Global Intestinal Fistula Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Immunosuppressants
• Antisecretory Agents
• Pain Management Medications
• 6.6. Global Intestinal Fistula Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fistula Closure Surgery
• Bowel Resection Surgery
• Stoma Formation Surgery
• 6.7. Global Intestinal Fistula Treatment Market, Sub-Segmentation Of Nutritional Support, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral Nutrition
• Enteral Nutrition
• 6.8. Global Intestinal Fistula Treatment Market, Sub-Segmentation Of Other Treatment Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hyperbaric Oxygen Therapy
• Endoscopic Fistula Closure

7. Intestinal Fistula Treatment Market Regional And Country Analysis

• 7.1. Global Intestinal Fistula Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Intestinal Fistula Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intestinal Fistula Treatment Market

• 8.1. Asia-Pacific Intestinal Fistula Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intestinal Fistula Treatment Market

• 9.1. China Intestinal Fistula Treatment Market Overview
• 9.2. China Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intestinal Fistula Treatment Market

• 10.1. India Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intestinal Fistula Treatment Market

• 11.1. Japan Intestinal Fistula Treatment Market Overview
• 11.2. Japan Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intestinal Fistula Treatment Market

• 12.1. Australia Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intestinal Fistula Treatment Market

• 13.1. Indonesia Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intestinal Fistula Treatment Market

• 14.1. South Korea Intestinal Fistula Treatment Market Overview
• 14.2. South Korea Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intestinal Fistula Treatment Market

• 15.1. Western Europe Intestinal Fistula Treatment Market Overview
• 15.2. Western Europe Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intestinal Fistula Treatment Market

• 16.1. UK Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intestinal Fistula Treatment Market

• 17.1. Germany Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intestinal Fistula Treatment Market

• 18.1. France Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intestinal Fistula Treatment Market

• 19.1. Italy Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intestinal Fistula Treatment Market

• 20.1. Spain Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intestinal Fistula Treatment Market

• 21.1. Eastern Europe Intestinal Fistula Treatment Market Overview
• 21.2. Eastern Europe Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intestinal Fistula Treatment Market

• 22.1. Russia Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intestinal Fistula Treatment Market

• 23.1. North America Intestinal Fistula Treatment Market Overview
• 23.2. North America Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intestinal Fistula Treatment Market

• 24.1. USA Intestinal Fistula Treatment Market Overview
• 24.2. USA Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intestinal Fistula Treatment Market

• 25.1. Canada Intestinal Fistula Treatment Market Overview
• 25.2. Canada Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intestinal Fistula Treatment Market

• 26.1. South America Intestinal Fistula Treatment Market Overview
• 26.2. South America Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intestinal Fistula Treatment Market

• 27.1. Brazil Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intestinal Fistula Treatment Market

• 28.1. Middle East Intestinal Fistula Treatment Market Overview
• 28.2. Middle East Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intestinal Fistula Treatment Market

• 29.1. Africa Intestinal Fistula Treatment Market Overview
• 29.2. Africa Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intestinal Fistula Treatment Market Competitive Landscape And Company Profiles

• 30.1. Intestinal Fistula Treatment Market Competitive Landscape
• 30.2. Intestinal Fistula Treatment Market Company Profiles
  • 30.2.1. Merck & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Intestinal Fistula Treatment Market Other Major And Innovative Companies

• 31.1. Medtronic plc
• 31.2. Eli Lilly and Company
• 31.3. Moderna Inc.
• 31.4. Astellas Pharma Inc.
• 31.5. Boehringer Ingelheim International GmbH
• 31.6. Cook Group Incorporated
• 31.7. Integra LifeSciences
• 31.8. Avante Health Solutions
• 31.9. Angiplast Pvt. Ltd.
• 31.10. Angiplast Pvt. Ltd.
• 31.11. Biolitec AG
• 31.12. Sklar Surgical Instruments
• 31.13. Livealth BioPharma
• 31.14. Surtex Instruments Limited
• 31.15. Advin Health Care

32. Global Intestinal Fistula Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intestinal Fistula Treatment Market

34. Recent Developments In The Intestinal Fistula Treatment Market

35. Intestinal Fistula Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Intestinal Fistula Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Intestinal Fistula Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Intestinal Fistula Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer